Who owns MARKER THERAPEUTICS INC COM NEW?
- Ticker: MRKR
- CUSIP Number: 57055l206
Tip: Access positions for across all investors
Analyze quarterly positions in Marker Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marker Therapeutics stock
Who bought or sold MARKER THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 1.6M | $2.1M | 0% | Mar 2026 |
|
| Blue Owl Capital Holdings | 554k | $826k | 0% | Dec 2025 |
|
| Vanguard Capital Management | 389k | $506k | 100% | Mar 2026 |
|
| Vanguard Group | 346k | $516k | 15% | Dec 2025 |
|
| Aisling Capital Management | 325k | $423k | 0% | Mar 2026 |
|
| Geode Capital Management | 161k | $209k | 23% | Mar 2026 |
|
| Renaissance Technologies | 124k | $184k | 16% | Dec 2025 |
|
| Advisor Group Holdings | 94k | $141k | 16% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 87k | $113k | 100% | Mar 2026 |
|
| LPL Financial | 83k | $108k | 0% | Mar 2026 |
|
| Two Sigma Investments | 61k | $79k | -38% | Mar 2026 |
|
| XTX Topco | 58k | $87k | 167% | Dec 2025 |
|
| Jane Street | 36k | $47k | -10% | Mar 2026 |
|
| UBS Group | 32k | $42k | -81% | Mar 2026 |
|
| Invst | 29k | $38k | 7% | Mar 2026 |
|
| Northern Trust | 26k | $39k | 140% | Dec 2025 |
|
| State Street Corporation | 21k | $31k | 0% | Dec 2025 |
|
| Creative Planning | 17k | $23k | 0% | Mar 2026 |
|
| Ashton Thomas Private Wealth | 16k | $21k | 64% | Mar 2026 |
|
| Matrix Asset Advisors | 15k | $20k | 0% | Mar 2026 |
|
| Hrt Financial | 12k | $15k | -15% | Mar 2026 |
|
| Two Sigma Securities | 12k | $15k | 100% | Mar 2026 |
|
| Fifth Third Bancorp | 10k | $13k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 2.5k | $3.3k | 100% | Mar 2026 |
|
| International Assets Investment Management | 2.0k | $2.6k | 0% | Mar 2026 |
|
| Tower Research Capital | 714.00 | $1.1k | 100% | Dec 2025 |
|
| Western Wealth Management | 368.00 | $477.995200 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 232.00 | $301.994400 | -4% | Mar 2026 |
|
| Signature | 228.00 | $295.989600 | 100% | Mar 2026 |
|
| SBI Securities | 203.00 | $264.001500 | 0% | Mar 2026 |
|
| Group One Trading | 178.00 | $231.008400 | 0% | Mar 2026 |
|
| Hilltop National Bank | 73.00 | $95.002200 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $29.998900 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $3.999900 | 100% | Mar 2026 |
|
| Morgan Stanley | 2.00 | $2.000000 | -87% | Mar 2026 |
|
Who sold out of Marker Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goss Wealth Management | Dec 2025 | 149k | $222k |
| Citadel Advisors | Dec 2025 | 59k | $88k |
| Boyer Financial Services | Dec 2025 | 37k | $57k |
| Virtu Financial | Sep 2025 | 28k | $25k |
| BlackRock | Dec 2025 | 992.00 | $1.5k |
| FMR | Sep 2025 | 150.00 | $133.995000 |
| Jpmorgan Chase & Co | Sep 2025 | 23.00 | $20.999000 |